Prevalence Assessment of Neisseria gonorrhoeae and Chlamydia trachomatis Infections among Pregnant Women Visiting Antenatal Care Centres of Thailand

• Conditions: eisseria gonorrhoeae, and Chlamydia trachomatis infection in pregnant women; Pregnancy; Neisseria gonorrhoeae; Chlamydia trachomatis; Prevalence

• Registration Number: TCTR20240701002
• Lead Sponsor: GARDP Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-01
• Last Update Posted: 19 August 2024
• Study Completion: 2024-10-31

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 849

Inclusion Criteria

Willingness and ability to give written informed consent or be consented by a legal representative.
Pregnant women aged between 15 and 49 years.
Pregnant women attending the ANC clinic during the study period irrespective of their gestational age.
Willingness and ability to provide laboratory specimen (vaginal swab) for NAAT tests for NG and CT.

Exclusion Criteria

Pregnant woman who previously visited the ANC clinic during the study period and has been enrolled in the study (to avoid duplicate sampling).
Pregnant women who do not give their informed consent to participate in the study.
Pregnant women who do not understand Thai language.
Pregnant women who are at high risk of abortion i.e. Recurrent pregnancy loss, threatened abortion, cervical conization.
Use of any systemic or intravaginal antibiotics with activity against NG within 30 days prior to screening

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chlamydia and/or gonorrhea infection Day 1 nucleic acid amplification test (NAAT)

Secondary Outcome Measures

Name	Time	Method
impact of STI prevention within few years after study end NA